Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 700049641000036119 | Trifeme (ethinyloestradiol 30 microgram + levonorgestrel 125 microgram) tablet: film-coated [10 tablets] (&) (ethinyloestradiol 30 microgram + levonorgestrel 50 microgram) sugar coated tablet [6 tablets] (&) (ethinyloestradiol 40 microgram + levonorgestrel 75 microgram) sugar coated tablet [5 tablets] (&) (inert substance) sugar coated tablet [7 tablets], 28 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 700049651000036116 | Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | Trifeme (levonorgestrel 125 microgram + ethinyloestradiol 30 microgram) tablet: film-coated | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | Trifeme (inert substance) tablet | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | Trifeme (levonorgestrel 50 microgram + ethinylestradiol 30 microgram) tablet | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | Is a | Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28 | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | has container type | blister pack | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | has TPUU | Trifeme (levonorgestrel 75 microgram + ethinylestradiol 40 microgram) tablet | false | Inferred relationship | Some | ||
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | has TP | Trifeme | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has subpack | False | Trifeme (6 x 50 microgram/30 microgram tablets, 5 x 75 microgram/40 microgram tablets, 10 x 125 microgram/30 microgram tablets, 7 x inert tablets), 28, blister pack | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR